Batch -13.pptx lung cancer detection using transfer learninghananth1513
Embedded systems
Embedded systems are special-purpose computing systems embedded in application environments or in other computing systems and provide specialized support. The decreasing cost of processing power, combined with the decreasing cost of memory and the ability to design low-cost systems on chip, has led to the development and deployment of embedded computing systems in a wide range of application environments. Examples include network adapters for computing systems and mobile phones, control systems for air conditioning, industrial systems, and cars,
Design of an Intelligent System for Improving Classification of Cancer DiseasesMohamed Loey
The methodologies that depend on gene expression profile have been able to detect cancer since its inception. The previous works have spent great efforts to reach the best results. Some researchers have achieved excellent results in the classification process of cancer based on the gene expression profile using different gene selection approaches and different classifiers
Early detection of cancer increases the probability of recovery. This thesis presents an intelligent decision support system (IDSS) for early diagnosis of cancer-based on the microarray of gene expression profiles. The problem of this dataset is the little number of examples (not exceed hundreds) comparing to a large number of genes (in thousands). So, it became necessary to find out a method for reducing the features (genes) that are not relevant to the investigated disease to avoid overfitting. The proposed methodology used information gain (IG) for selecting the most important features from the input patterns. Then, the selected features (genes) are reduced by applying the Gray Wolf Optimization algorithm (GWO). Finally, the methodology exercises support vector machine (SVM) for cancer type classification. The proposed methodology was applied to three data sets (breast, colon, and CNS) and was evaluated by the classification accuracy performance measurement, which is most important in the diagnosis of diseases. The best results were gotten when integrating IG with GWO and SVM rating accuracy improved to 96.67% and the number of features was reduced to 32 feature of the CNS dataset.
This thesis investigates several classification algorithms and their suitability to the biological domain. For applications that suffer from high dimensionality, different feature selection methods are considered for illustration and analysis. Moreover, an effective system is proposed. In addition, Experiments were conducted on three benchmark gene expression datasets. The proposed system is assessed and compared with related work performance.
import pygame
pygame.init() #initializes the Pygame
from pygame.locals import* #import all modules from Pygame
screen = pygame.display.set_mode((798,600))
#changing title of the game window
pygame.display.set_caption('Racing Beast')
#changing the logo
logo = pygame.image.load('car game/logo.jpeg')
pygame.display.set_icon(logo)
run = True
while run:
for event in pygame.event.get():
if event.type == pygame.QUIT:
run = False
if event.type == pygame.KEYDOWN:
if event.key == K_RIGHT:
maincarX += 5
if event.key == K_LEFT:
maincarX -= 5
#CHANGING COLOR WITH RGB VALUE, RGB = RED, GREEN, BLUE
screen.fill((255,0,0))
Batch -13.pptx lung cancer detection using transfer learninghananth1513
Embedded systems
Embedded systems are special-purpose computing systems embedded in application environments or in other computing systems and provide specialized support. The decreasing cost of processing power, combined with the decreasing cost of memory and the ability to design low-cost systems on chip, has led to the development and deployment of embedded computing systems in a wide range of application environments. Examples include network adapters for computing systems and mobile phones, control systems for air conditioning, industrial systems, and cars,
Design of an Intelligent System for Improving Classification of Cancer DiseasesMohamed Loey
The methodologies that depend on gene expression profile have been able to detect cancer since its inception. The previous works have spent great efforts to reach the best results. Some researchers have achieved excellent results in the classification process of cancer based on the gene expression profile using different gene selection approaches and different classifiers
Early detection of cancer increases the probability of recovery. This thesis presents an intelligent decision support system (IDSS) for early diagnosis of cancer-based on the microarray of gene expression profiles. The problem of this dataset is the little number of examples (not exceed hundreds) comparing to a large number of genes (in thousands). So, it became necessary to find out a method for reducing the features (genes) that are not relevant to the investigated disease to avoid overfitting. The proposed methodology used information gain (IG) for selecting the most important features from the input patterns. Then, the selected features (genes) are reduced by applying the Gray Wolf Optimization algorithm (GWO). Finally, the methodology exercises support vector machine (SVM) for cancer type classification. The proposed methodology was applied to three data sets (breast, colon, and CNS) and was evaluated by the classification accuracy performance measurement, which is most important in the diagnosis of diseases. The best results were gotten when integrating IG with GWO and SVM rating accuracy improved to 96.67% and the number of features was reduced to 32 feature of the CNS dataset.
This thesis investigates several classification algorithms and their suitability to the biological domain. For applications that suffer from high dimensionality, different feature selection methods are considered for illustration and analysis. Moreover, an effective system is proposed. In addition, Experiments were conducted on three benchmark gene expression datasets. The proposed system is assessed and compared with related work performance.
import pygame
pygame.init() #initializes the Pygame
from pygame.locals import* #import all modules from Pygame
screen = pygame.display.set_mode((798,600))
#changing title of the game window
pygame.display.set_caption('Racing Beast')
#changing the logo
logo = pygame.image.load('car game/logo.jpeg')
pygame.display.set_icon(logo)
run = True
while run:
for event in pygame.event.get():
if event.type == pygame.QUIT:
run = False
if event.type == pygame.KEYDOWN:
if event.key == K_RIGHT:
maincarX += 5
if event.key == K_LEFT:
maincarX -= 5
#CHANGING COLOR WITH RGB VALUE, RGB = RED, GREEN, BLUE
screen.fill((255,0,0))
Novel Functional Radiomics for Prediction of Cardiac PET Avidity in Lung Canc...Wookjin Choi
Purpose/Objective(s)
Traditional methods of evaluating cardiotoxicity focus solely on radiation doses to the heart and do not incorporate functional imaging information. Functional imaging has great potential to improve the ability to provide early prediction for cardiotoxicity for lung cancer patients undergoing radiotherapy. FDG-based PET/CT imaging is routinely obtained as part of standard staging work up for lung cancer patients. Although FDG PET/CT scans are typically used to evaluate the tumor, imaging guidelines note that FDG PET/CT scans are an FDA-approved method to image for cardiac inflammation, and studies have noted that the PET cardiac signal can be predictive of clinical outcomes. The purpose of this work was to develop a radiomics model to predict clinical cardiac assessment of standard of care FDG PET/CT scans.
Materials/Methods
The study included 100 consecutive lung cancer patients treated with radiotherapy who underwent standard pre-treatment FDG-PET/CT staging scans. A clinician reviewed the PET/CT scans per clinical cardiac assessment guidelines and classified the cardiac uptake as: 0 = uniform diffuse, 1 = absent, 2 = heterogeneous, with event rates of 20%, 44%, and 35%, respectively. The heart was delineated and 200 novel functional radiomics features were selected to classify cardiac FDG uptake patterns. We divided the data into an 80% training set and a 20% test set to train and evaluate the classification models. Feature reduction was carried out using the Wilcoxon test (with Bonferroni adjusted p<0.05), hierarchical clustering, and Recursive Feature Elimination. Two automatic machine learning (AutoML) frameworks were used to determine classification models: a Random Forest Classifier (Tree-based Pipeline Optimization Tool, TPOT) and Linear Discriminant Analysis (AutoSklearn). 10-fold cross validation was carried out for training and the accuracy of the ability of the models to predict for clinical cardiac assessment is reported.
Results
Fifty-one independent radiomics features were reduced to 3 clinically pertinent features (PET 2D Skewness, PET Grey Level Co-occurrence Matrix Correlation, and PET Median) using feature reduction techniques. The model selected by TPOT showed 89.8% predictive accuracy in the cross validation of the training set and 85% predictive accuracy on the test set. The model selected by AutoSklearn showed 89.7% predictive accuracy in the cross validation of the training set and 80% predictive accuracy on the test set.
Conclusion
The novelty of this work is that it is the first study to develop and evaluate functional cardiac radiomic features from standard of care FDG PET/CT scans with the data showing good predictive accuracy with clinical imaging evaluation. If validated, the current work provides automated methods to provide functional cardiac information using standard of care imaging that can be used as an imaging biomarker for early clinical toxicity prediction for lung cancer patients.
Automatic System for Detection and Classification of Brain TumorsFatma Sayed Ibrahim
Automatic system for brain tumors detection based on DICOM MRI images
Surveying methodologies of from preprocessing to classifications
Implementing comparative study.
Proposed technique with highest accuracy and lest elapsed time.
Practical aspects of medical image ai for hospital (IRB course)Sean Yu
Introduction of medical imaging AI, especially in digital pathology. The talk focused on how we come up with different projects, how to define the scope and challenges of these projects.
Breast Cancer Diagnosis using a Hybrid Genetic Algorithm for Feature Selection based on Mutual Information (Abeer Alzubaidi, Georgina Cosma, David Brown and Graham Pockley)
Interactive Technologies and Games (ITAG) Conference 2016
Health, Disability and EducationDates: Wednesday 26 October 2016 - Thursday 27 October 2016 Location: The Council House, NG1 2DT
Deep Generative model-based quality control for cardiac MRI segmentation Seunghyun Hwang
Review : Deep Generative model-based quality control for cardiac MRI segmentation
- by Seunghyun Hwang (Yonsei University, Severance Hospital, Center for Clinical Data Science)
Biological variation as an uncertainty componentGH Yeoh
To assist the clinical interpretation of a test result, there is a necessity to have an additional non-analytical component in the overall estimation of UM, namely the biological variation.
Radiomics Analysis of Pulmonary Nodules in Low Dose CT for Early Detection of...Wookjin Choi
Purpose: To predict the histopathologic subtypes with poor surgery prognosis in early stage lung adenocarcinomas using CT and PET radiomics.
Methods: We retrospectively enrolled 53 patients with stage I lung adenocarcinoma who underwent both diagnostic CT and 18F-fluorodeoxyglucose (FDG) PET/CT before complete surgical resection of the tumors. Tumor segmentation was manually contoured by a physician on both the diagnostic CT and the attenuation CT of PET/CT.A total of 170 radiomics features were extracted on both PET and CT images to design predictive models for two histopathologic endpoints: (1) tumors with solid or micropapillary predominant subtype (aggressiveness), and (2) tumors with micropapillary component more than 5% (MIP5). We used least absolute shrinkage and selection operator (LASSO) as a model building method coupled with a class separability feature selection (CSFS) method. For an unbiased model estimate, a 10-fold cross validation approach was used. The area under the curve (AUC) and prediction accuracy were employed to evaluate the performance of the model. P-values were computed using Wilcoxon rank-sum test.
Results: Of the 53 patients, 9 and 15 had tumors with aggressiveness and MIP5, respectively. For both endpoints, LASSO models with two PET radiomics features achieved the best performance. For aggressiveness, the LASSO model with PET Cluster Shade and PET 2D Variance resulted in 77.6±2.3% accuracy and 0.71±0.02 AUC (P = 0.011). For MIP5, the LASSO model with PET Eccentricity and PET Cluster Shade resulted in 69.6±3.1% accuracy and 0.68±0.04 AUC (P=0.014). The PET Cluster Shade was commonly selected in both models. Cluster shade is a texture feature that measures the skewness of the co-occurrence matrix. Higher PET cluster shade predicted that the tumor was more aggressive and more likely MIP5.
Conclusion: We showed that PET/CT radiomics features can predict tumor aggressiveness.
Funding Support, Disclosures, and Conflict of Interest: This work was supported in part by the National Cancer Institute Grants R01CA172638.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Novel Functional Radiomics for Prediction of Cardiac PET Avidity in Lung Canc...Wookjin Choi
Purpose/Objective(s)
Traditional methods of evaluating cardiotoxicity focus solely on radiation doses to the heart and do not incorporate functional imaging information. Functional imaging has great potential to improve the ability to provide early prediction for cardiotoxicity for lung cancer patients undergoing radiotherapy. FDG-based PET/CT imaging is routinely obtained as part of standard staging work up for lung cancer patients. Although FDG PET/CT scans are typically used to evaluate the tumor, imaging guidelines note that FDG PET/CT scans are an FDA-approved method to image for cardiac inflammation, and studies have noted that the PET cardiac signal can be predictive of clinical outcomes. The purpose of this work was to develop a radiomics model to predict clinical cardiac assessment of standard of care FDG PET/CT scans.
Materials/Methods
The study included 100 consecutive lung cancer patients treated with radiotherapy who underwent standard pre-treatment FDG-PET/CT staging scans. A clinician reviewed the PET/CT scans per clinical cardiac assessment guidelines and classified the cardiac uptake as: 0 = uniform diffuse, 1 = absent, 2 = heterogeneous, with event rates of 20%, 44%, and 35%, respectively. The heart was delineated and 200 novel functional radiomics features were selected to classify cardiac FDG uptake patterns. We divided the data into an 80% training set and a 20% test set to train and evaluate the classification models. Feature reduction was carried out using the Wilcoxon test (with Bonferroni adjusted p<0.05), hierarchical clustering, and Recursive Feature Elimination. Two automatic machine learning (AutoML) frameworks were used to determine classification models: a Random Forest Classifier (Tree-based Pipeline Optimization Tool, TPOT) and Linear Discriminant Analysis (AutoSklearn). 10-fold cross validation was carried out for training and the accuracy of the ability of the models to predict for clinical cardiac assessment is reported.
Results
Fifty-one independent radiomics features were reduced to 3 clinically pertinent features (PET 2D Skewness, PET Grey Level Co-occurrence Matrix Correlation, and PET Median) using feature reduction techniques. The model selected by TPOT showed 89.8% predictive accuracy in the cross validation of the training set and 85% predictive accuracy on the test set. The model selected by AutoSklearn showed 89.7% predictive accuracy in the cross validation of the training set and 80% predictive accuracy on the test set.
Conclusion
The novelty of this work is that it is the first study to develop and evaluate functional cardiac radiomic features from standard of care FDG PET/CT scans with the data showing good predictive accuracy with clinical imaging evaluation. If validated, the current work provides automated methods to provide functional cardiac information using standard of care imaging that can be used as an imaging biomarker for early clinical toxicity prediction for lung cancer patients.
Automatic System for Detection and Classification of Brain TumorsFatma Sayed Ibrahim
Automatic system for brain tumors detection based on DICOM MRI images
Surveying methodologies of from preprocessing to classifications
Implementing comparative study.
Proposed technique with highest accuracy and lest elapsed time.
Practical aspects of medical image ai for hospital (IRB course)Sean Yu
Introduction of medical imaging AI, especially in digital pathology. The talk focused on how we come up with different projects, how to define the scope and challenges of these projects.
Breast Cancer Diagnosis using a Hybrid Genetic Algorithm for Feature Selection based on Mutual Information (Abeer Alzubaidi, Georgina Cosma, David Brown and Graham Pockley)
Interactive Technologies and Games (ITAG) Conference 2016
Health, Disability and EducationDates: Wednesday 26 October 2016 - Thursday 27 October 2016 Location: The Council House, NG1 2DT
Deep Generative model-based quality control for cardiac MRI segmentation Seunghyun Hwang
Review : Deep Generative model-based quality control for cardiac MRI segmentation
- by Seunghyun Hwang (Yonsei University, Severance Hospital, Center for Clinical Data Science)
Biological variation as an uncertainty componentGH Yeoh
To assist the clinical interpretation of a test result, there is a necessity to have an additional non-analytical component in the overall estimation of UM, namely the biological variation.
Radiomics Analysis of Pulmonary Nodules in Low Dose CT for Early Detection of...Wookjin Choi
Purpose: To predict the histopathologic subtypes with poor surgery prognosis in early stage lung adenocarcinomas using CT and PET radiomics.
Methods: We retrospectively enrolled 53 patients with stage I lung adenocarcinoma who underwent both diagnostic CT and 18F-fluorodeoxyglucose (FDG) PET/CT before complete surgical resection of the tumors. Tumor segmentation was manually contoured by a physician on both the diagnostic CT and the attenuation CT of PET/CT.A total of 170 radiomics features were extracted on both PET and CT images to design predictive models for two histopathologic endpoints: (1) tumors with solid or micropapillary predominant subtype (aggressiveness), and (2) tumors with micropapillary component more than 5% (MIP5). We used least absolute shrinkage and selection operator (LASSO) as a model building method coupled with a class separability feature selection (CSFS) method. For an unbiased model estimate, a 10-fold cross validation approach was used. The area under the curve (AUC) and prediction accuracy were employed to evaluate the performance of the model. P-values were computed using Wilcoxon rank-sum test.
Results: Of the 53 patients, 9 and 15 had tumors with aggressiveness and MIP5, respectively. For both endpoints, LASSO models with two PET radiomics features achieved the best performance. For aggressiveness, the LASSO model with PET Cluster Shade and PET 2D Variance resulted in 77.6±2.3% accuracy and 0.71±0.02 AUC (P = 0.011). For MIP5, the LASSO model with PET Eccentricity and PET Cluster Shade resulted in 69.6±3.1% accuracy and 0.68±0.04 AUC (P=0.014). The PET Cluster Shade was commonly selected in both models. Cluster shade is a texture feature that measures the skewness of the co-occurrence matrix. Higher PET cluster shade predicted that the tumor was more aggressive and more likely MIP5.
Conclusion: We showed that PET/CT radiomics features can predict tumor aggressiveness.
Funding Support, Disclosures, and Conflict of Interest: This work was supported in part by the National Cancer Institute Grants R01CA172638.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYNEHA GUPTA
The process of drug discovery and development is a complex and multi-step endeavor aimed at bringing new pharmaceutical drugs to market. It begins with identifying and validating a biological target, such as a protein, gene, or RNA, that is associated with a disease. This step involves understanding the target's role in the disease and confirming that modulating it can have therapeutic effects. The next stage, hit identification, employs high-throughput screening (HTS) and other methods to find compounds that interact with the target. Computational techniques may also be used to identify potential hits from large compound libraries.
Following hit identification, the hits are optimized to improve their efficacy, selectivity, and pharmacokinetic properties, resulting in lead compounds. These leads undergo further refinement to enhance their potency, reduce toxicity, and improve drug-like characteristics, creating drug candidates suitable for preclinical testing. In the preclinical development phase, drug candidates are tested in vitro (in cell cultures) and in vivo (in animal models) to evaluate their safety, efficacy, pharmacokinetics, and pharmacodynamics. Toxicology studies are conducted to assess potential risks.
Before clinical trials can begin, an Investigational New Drug (IND) application must be submitted to regulatory authorities. This application includes data from preclinical studies and plans for clinical trials. Clinical development involves human trials in three phases: Phase I tests the drug's safety and dosage in a small group of healthy volunteers, Phase II assesses the drug's efficacy and side effects in a larger group of patients with the target disease, and Phase III confirms the drug's efficacy and monitors adverse reactions in a large population, often compared to existing treatments.
After successful clinical trials, a New Drug Application (NDA) is submitted to regulatory authorities for approval, including all data from preclinical and clinical studies, as well as proposed labeling and manufacturing information. Regulatory authorities then review the NDA to ensure the drug is safe, effective, and of high quality, potentially requiring additional studies. Finally, after a drug is approved and marketed, it undergoes post-marketing surveillance, which includes continuous monitoring for long-term safety and effectiveness, pharmacovigilance, and reporting of any adverse effects.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
1. Joel Carlson, Sung-Joon Ye
MSc Student
Radiological Physics Lab
Seoul National University
A Radiomics Approach to the
Classification of Astrocytoma
and Oligodendroglioma
http://joelcarlson.me
@jnkcarlson
3. Is it reproducible?
Not really.
-Concordance index among 4 experienced
neuropathologists: 52-70%
The Challenge and Problem
Correct classification of glioma category essential for
physicians and patients:
-Therapy choices
-Understanding prognosis
Oligodendroglioma
Astrocytoma
*
*
Current Method:
Neuropathologists determine classification
-Based on biopsy specimen
-Relatively subjective
5. Types of Features
Wndchrm
-Raw image features
-Transformed image features
-Compound transform features
Texture via Radiomics R package
-First order features (energy, entropy, etc)
-GLCM, GLRLM (rotation invariant)
-Thibault matrices: GLSZM, MGLSZM
Nuclei features
-Area, perimeter, max. diameter, skewness, kurtosis, etc)
Raw Fourier Transform
LoG
Edge
6. Pathology: Regions of Interest
Raw image
Superior method: Tiling
Select 5 ROIs
For each ROI calculate
wndchrm features
7. Steps:
1. Raw image (each pathology ROI)
2. Color Deconvolution
a. Eosin
b. Hematoxylin
3. Thresholding
– Gaussian blur
– Fill holes
– Watershed
4. Nuclei detection
– Area greater than some constant
5. Apply mask to raw image
6. Calculate Nuclei features
Pathology: Nuclei Segmentation
8. Radiology: Extraction of tumor components
BraTumIa used to segment tumor
1. Mask raw image with classification
2. Extract masked region for each
component
3. Calculate Features
– Wndchrm
– Textures
For the slice that most heavily
expresses a given component:
9. Model Building
3 Phases in a loop:
1. Create random samples:
– Patients (training/validation)
– Data
2. Permute data and combine; train models for each
permutation
3. Validate models; make and save predictions
10. Phase 1: Sampling Patients and Data
Sample Training and validation patients:
Sample data types:
Radiological
Full Tumor
Edema
Necrotic
Enhancing
Non-Enhancing
T1c
FLAIR
Image Type:
Choose 1
Tissue Type:
Choose 1
Nuclei
Pathological
1
2
3
4
5
ROI:
Choose 1
Training • 75% of patients
Validation • 25% of patients
11. Phase 2: Creating Permutations and Training
*Generalized Linear Model (LOOCV to determine regularization)
Rwnd_Rtext
Rwnd_Pwnd
Rwnd_Nshape
Rtext_Pwnd
Rtext_Nshape
Nuclei
Pwnd_NShape
Radiological
Texture
Pathological
wndchrm
Radiological
wndchrm
Nuclei
Shape
Train Model
for each
permutation
*
Pre-Process
(Center, Scale,
PCA)
Make Test
Set Predictions
Make Validation
Set Predictions
12. Phase 3: Validation and Predictions
For each model trained:
• Calculate Cross validation accuracy on validation set (25% of patients)
• Save predictions of each model on testing set
Final Predictions
• Majority class as voted by
models with:
• CV accuracy > 85%
• More than 3 variables
included in model
14. Results – CV Accuracy Density Histograms
Mean CV Accuracy: 0.502
Only Non-Enhancing
shows predictive ability
greater than chance on
CV accuracy
Models with CV Acc > 0.85
used for predictions
16. Exploring the Non-Enhancing CV Accuracy
Mean CV Acc: 0.502
All Models
1.Mean CV Acc: 0.608
NonEnhancing
2.Mean CV Acc: 0.651
NonEnhancing,
Select Models
17. Exploring the Non-Enhancing CV Accuracy
Mean CV Acc: 0.502
All Models
1.Mean CV Acc: 0.608
NonEnhancing
2.Mean CV Acc: 0.651
NonEnhancing,
Select Models
3.Mean CV Acc: 0.688
NonEnhancing,
Select Models,
T1c only
18. 4.Mean CV Acc: 0.734
NonEnhancing,
Rwnd_Rtext only,
T1c only
Exploring the Non-Enhancing CV Accuracy
Mean CV Acc: 0.502
All Models
1.Mean CV Acc: 0.608
NonEnhancing
2.Mean CV Acc: 0.651
NonEnhancing,
Select Models
3.Mean CV Acc: 0.688
NonEnhancing,
Select Models,
T1c only
19. Conclusions
Radiological WNDCHRM and Texture features provide
useful and orthogonal information
-Nuclei features show some promise (not discussed)
Majority of features not useful
Using PCA obfuscates which features may be useful
Better predictions may take into account dependence of CV accuracy
on number of variables
Mean CV accuracy of all models with >3 variables: ~0.5
Mean CV accuracy of select models* with > 16 variables: ~0.7
*Certain T1c Non-Enhancing models (Rtext, Rwnd, Rwnd_Rtext)
21. Four categories
• High contrast features
• Edges, connected components,
spatial distribution, size and
shape
• Polynomial decompositions
• A polynomial that
approximates the image to
some fidelity is generated.
Coefficients used as
descriptors.
• High contrast features
• Edges, connected components,
spatial distribution, size and
shape
• Pixel statistics
• Pixel intensities within the
image (histograms, moments)
The WNDCHRM Feature Set
Editor's Notes
Oligodendroglioma
Round, regular, monotonous nuclei
Open chromatin
Perinuclear cytoplasmic clearing (fried egg pattern)
Prone to microcalcifications
Astrocytoma
Elongated, irregular, enlarged nuclei
Hyperchromatic hue
Long, fine fibrillary processes